Contrast Media & Molecular Imaging / 2021 / Article / Tab 3 / Review Article
Diagnostic Accuracy of 18F-FDG-PET/CT and MRI in Predicting the Tumor Response in Locally Advanced Cervical Carcinoma Treated by Chemoradiotherapy: A Meta-Analysis Table 3 Patients’ pathologic and imaging characteristics.
Author FIGO stage Histopathology Pelvic LN metastasis Prevalence of distant metastasis 3-OS DFI (month) MTV TLG Persistence CR PFS SUVmean IB IIA-IIB IIIA-IIIB SCC Adenocarcinoma Partial response Complete response Rufini et al. 3 (3.4%) 72 (81.7%) 13 (14.7%) 77 (87.5%) 11 (12.5%) 40 (45.5%) 10 (11.4%) N/A 15.5 33.8 (1.2–180.0) 240.2 (7.9–2417.0) N/A N/A N/A 2.1 (1.1–5.7) 1.8 ± 0.7 Cetina et al. 2/16 (12%) 8/16 (50%) 3/16 (19%) 15/16-(94%) 1 (6.2%) N/A N/A N/A 14.5 N/A N/A N/A N/A N/A N/A N/A Perrone et al. N/A N/A N/A 32 (80%) 8 (20%) 17 (42.5%) 1 (2.5%) 88% N/A N/A N/A 8 (20%) 33 (82.5%) 78% 7.5 ± 5.1 N/A Chen et al. 37 (26%) 78 (55%) 27 (19%) 114 (80%) 28 (20%) 61 (43%) 27 (19%) N/A N/A 28.1 ± 42.7 216.1 ± 280.5 22 (15%) 120 (84%) N/A 5.12 ± 1.17 1.28 Choi et al. 3 (1.9%) 102 (75%) 17 (12.4%) 124 (91.2%) 9 (6.6%) N/A 12 (22.2%) N/A N/A N/A N/A 18 (13.2%) 124 (91%) N/A 5.7 ± 2.6 2.5 ± 0.8 Oh et al. 3 (5%) 46 (77%) 8 (13%) 52 (87%) 8 (13%) 42 (70%) 6 (10%) 93.6% N/A N/A N/A 4 (7%) 43 (73%) 71.9% N/A N/A
SCC: squamous cell carcinoma; LN: lymph node; DFI: disease-free interval; 3-OS: 3-month overall survival; MTV: metabolic tumor volume; TLG: total lesion glycolysis; CR: complete response; PFS: progression-free survival; and SUV: standardized uptake value.